219 related articles for article (PubMed ID: 9055967)
1. Optimization of prothrombin time measurements in canine plasma.
Mischke R; Nolte I
Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
3. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
Mischke R
Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
[TBL] [Abstract][Full Text] [Related]
4. Automated synthetic substrate assays for coagulopathies of dogs.
Bonk RJ; Swanson MB; Malya PA
Lab Anim Sci; 1986 Oct; 36(5):517-21. PubMed ID: 3773465
[TBL] [Abstract][Full Text] [Related]
5. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
Yasunaga C; Suehisa E; Toku M; Kawasaki T; Hidaka Y
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):597-600. PubMed ID: 18685445
[TBL] [Abstract][Full Text] [Related]
7. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
8. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
Deniz A; Mischke R; Nolte I
Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of different prothrombin time assays to factor VII deficiency in canine plasma.
Mischke R; Diedrich M; Nolte I
Vet J; 2003 Jul; 166(1):79-85. PubMed ID: 12788020
[TBL] [Abstract][Full Text] [Related]
10. Prothrombin time standardisation in canine samples with regard to inter-batch and inter-reagent variability.
Mischke R
Vet J; 2011 Jun; 188(3):301-6. PubMed ID: 20655250
[TBL] [Abstract][Full Text] [Related]
11. Commercial variants of the prothrombin time test as a screening test of acquired coagulation factor II, VII, and X deficiencies in dogs.
Mischke R
Res Vet Sci; 2002 Oct; 73(2):165-70. PubMed ID: 12204636
[TBL] [Abstract][Full Text] [Related]
12. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
13. The influence of residual factor VII on the sensitivity of brain thromboplastin.
Spurling NW; Savory J
Thromb Haemost; 1978 Jun; 39(3):592-9. PubMed ID: 705687
[TBL] [Abstract][Full Text] [Related]
14. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
Badylak SF; Van Vleet JF
Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a prothrombin time optimized for the dog on plasmas with defined coagulation factor deficiency due to coumarin intoxication.
Mischke R
Zentralbl Veterinarmed A; 1995 Nov; 42(9):589-99. PubMed ID: 8822195
[TBL] [Abstract][Full Text] [Related]
16. Plasma predilution with addition of depleted plasma in a prothrombin time reagent improves the agreement between different prothrombin time methods.
Osman A; Lindahl TL
Scand J Clin Lab Invest; 2009; 69(3):395-400. PubMed ID: 19191068
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of congenital coagulation defects.
Lowe GD; Forbes CD
Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
[No Abstract] [Full Text] [Related]
18. Prothrombin time sensitivity and specificity to mild clotting factor deficiencies of the extrinsic pathway: evaluation of eight commercial thromboplastins.
Massignon D; Moulsma M; Bondon P; Debize G; Abidi H; Buttin T; Bon C; Pillonchery G; Coeur P
Thromb Haemost; 1996 Apr; 75(4):590-4. PubMed ID: 8743184
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
